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Selective venography versus nonselective
venography before vena cava filter placement:
Evidence for more, not less
Jeffrey S. Danetz, MD, Robert B. McLafferty, MD, Juan Ayerdi, MD, Laura A. Gruneiro, MD,
Don E. Ramsey, MD, and Kim J. Hodgson, MD, Springfield, Ill
Objective: We undertook this study to determine whether additional use of selective venography, compared with
nonselective venography alone, reveals more abnormal anatomic venous findings that lead to changes in vena cava filter
(VCF) position.
Methods: From January 1998 to June 2002, 94 patients underwent VCF placement by vascular surgeons at a university
tertiary care center. Indications, techniques, decision analysis, and complications were reviewed. Nonselective venography
and selective venography of the inferior vena cava (IVC) were evaluated for image quality, abnormal findings, aberrant
anatomy, and the anatomic relationship of vertebral bodies to major venous tributaries.
Results: Absolute and relative indications for VCF placement were 44% and 56%, respectively. Jugular, femoral, and
subclavian vein approach was used in 47%, 47%, and 6% of patients, respectively. Seventy-three percent of VCFs were
placed in the catheterization laboratory, 21% in the operating room, and 5% at the bedside. Nonselective venography was
performed in 80 patients (85%), of whom 44% had undergone selective venography. At nonselective venography plus
selective venography 7.5% of patients had an abnormal finding (IVC compression, n  3; IVC thrombus, n  2;
tortuosity, n  1). Similarly, 17.5% of patients had aberrant anatomy (accessory renal vein, n  8; IVC duplication, n 
3; large low right gonadal vein, n  2; megacava, n  2). Nonselective venography plus selective venography
demonstrated that 16% of VCFs required a major change in position, 10% of which were placed above the renal veins.
Compared with nonselective venography alone, selective venography enabled detection of significantly more abnormal
and aberrant findings (9% vs 49%; P < .001). Changes in VCF placement were necessary significantly more often in
patients undergoing additional selective venography compared with nonselective venography alone (31% vs 4%; P 
.003). In one patient in the series, a VCF was malpositioned in the iliac vein with intravascular ultrasound visualization.
Conclusion: When nonselective venography plus selective venography were performed, 23% of patients had either an
abnormal finding or aberrant anatomy, and most of these required a major change in VCF position. Nonselective
venography plus selective venography redefines the criterion standard and, because of limitations of other methods of
vena cava visualization for VCF deployment, should be performed in most patients. (J Vasc Surg 2003;38:928-34.)
Vena cava filters (VCFs) are frequently deployed during
treatment and prophylaxis of venous thromboembolism.
Since the initial description by Greenfield et al1 in 1973,
VCFs have been routinely used to prevent pulmonary em-
bolism. Absolute indications for VCF most commonly
observed in the setting of venous thromboembolism in-
clude contraindications to anticoagulation therapy, and
pulmonary embolism despite therapeutic anticoagulation.
In contrast, indications for prophylaxis against pulmonary
embolism in the absence of known venous thromboembo-
lism are more controversial, and include multitrauma, can-
cer, severe cardiopulmonary disease, hypercoagulable
states, and prolonged immobilization.2-4
Depending on institutional trends and physician train-
ing, different methods to optimally visualize the vena cava
are used in deployment of VCFs. Not uncommonly, VCFs
are placed with fluoroscopic guidance to identify the bony
landmarks of the vertebral bodies.5,6 More recently, tech-
nologic advances have led to placement of these devices
with visualization with either transabdominal ultrasound7,8
or intravascular ultrasound (IVUS).9-11 Proponents of ul-
trasound cite the advantages of better patient safety with
insertion at the bedside, portability, ease of placement with
reliable results, and cost containment.7-11 Potential short-
comings of ultrasound include difficulty in optimal venous
visualization, steep learning curve, limitations of access site,
and dependence on technologist skill.
Although contrast venography is used most often be-
fore VCF placement, little is known about how the discov-
ery of major venous anomalies leads to a decision to change
the position of the VCF.12-15 More important, there is
considerable debate as to whether the addition of selective
venography after nonselective venography reveals more
venous anomalies and thus redefines the criterion standard.
We examined our experience with nonselective venography
and selective venography for placement of VCFs.
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METHODS
A retrospective review was conducted of all consecutive
patients in whom a VCF was deployed by six vascular
surgeons between January 1998 and June 2002. All vascu-
lar surgeons were or are currently full-time faculty in the
Division of Vascular Surgery at Southern Illinois Univer-
sity, Springfield, Illinois. The procedures were performed at
two tertiary care centers, Memorial Medical Center and St
John’s Hospital. All patients in whom the VCF was de-
ployed in the inferior vena cava (IVC) were identified with
a prospectively maintained vascular registry (Patient Anal-
ysis and Tracking System; Axis Software, Portland, Ore)
and cross-referenced with the university practice billing
database (Signature Billing System; Siemens, Malvern, Pa),
to assure that no patients were overlooked. Information
obtained from the medical records included patient demo-
graphic data, risk factors, indications for VCF insertion,
periprocedural data, complications, procedure setting, and
changes in serum creatinine concentration in patients who
received intravenous contrast medium. Routine follow-up
consisted of patient evaluation at 4 to 6 hours after the
procedure and the following day. The study was approved
by the institutional review board.
VCF placement was performed after administration of
local anesthesia and sedation or with the patient under
general anesthesia if VCF placement was performed in
conjunction with a major operation. Generally the right
internal jugular vein was the preferred site for VCF inser-
tion. If this site could not be used because of problems such
as need for a cervical collar or previous right internal jugular
thrombosis, the right common femoral vein was the pre-
ferred insertion site. The method of VCF placement and
whether nonselective venography or selective venography
was used varied among vascular surgeons. Empiric place-
ment was performed with fluoroscopy to identify the third
lumbar vertebral body for deployment. IVC visualization
with IVUS was with either a 6F, 12.5 MHz or 9F, 9 MHz
IVUS catheter (Boston Scientific, Maple Grove, Minn).
Nonselective venography was performed with a 5F pigtail
catheter (Cordis, Miami, Fla). Nonselective plus selective
venography was performed with digital subtraction angiog-
raphy, with a 15-inch image intensifier. For nonselective
venography the pigtail catheter was positioned at the third
lumbar vertebral body, and 25 mL of nonionic contrast
agent was injected per second, for a total of 2 seconds, with
a power injector. Injection was at 600 psi while the patient
held respiration. Selective venography was performed by
hand injection of contrast material with a 10 mL syringe
attached to a four-way stopcock or manifold. Usually con-
trast material for hand injection was diluted with normal
saline solution to 50% concentration. First-order catheter-
ization for selective venography was in accordance with that
described in Current Procedural Terminology (Code
36011).16 Several techniques were used to perform selec-
tive venography. These included using curved catheters
(eg, 5F multipurpose catheter or 5F Cobra 2 catheter;
Cordis) to directly engage unknown IVC side branches,
and guide wire–directed catheter placement. Vena cava
diameter was measured selectively at the discretion of the
attending vascular surgeon. Cavamegaly was defined as
diameter 28 mm or greater.
VCF procedure privileges in the catheterization labo-
ratory and whether nonselective venography or selective
venography was performed varied among the six vascular
surgeons. One vascular surgeon (D.E.R.) placed VCFs only
in the operating room, using either lumbar bony landmarks
or nonselective venography. The remaining five vascular
surgeons (R.B.M., L.A.G., M.M.S., M.A.M., K.J.H.) also
had VCF procedure privileges in the catheterization labo-
ratory. For these five vascular surgeons, use of selective
venography in addition to nonselective venography varied.
Generally, one of the vascular surgeons (K.J.H.) routinely
performed selective venography of the renal veins, iliac
veins, or other venous anomalies, and the other four
(R.B.M., L.A.G., M.M.S., M.A.M.) performed selective
venography, depending on the quality of visualization of
venous tributaries at nonselective venography.
Venograms were reviewed in conjunction with the
information provided by the procedural report by an at-
tending vascular surgeon (R.B.M.) and a vascular fellow
(J.S.D.). Nonselective venograms were graded with the
criteria outlined in Table I. In brief, the quality of nonse-
lective venograms was based on whether the renal and iliac
veins could be reliably identified for safe VCF placement. In
addition, the lowest renal vein and common iliac vein
confluence was aligned with corresponding vertebral bod-
ies and disk spaces.
Venograms were also evaluated for abnormal findings
and aberrant anatomy. Abnormal findings included com-
pression, significant tortuosity, and presence of thrombus.
Aberrant anatomic findings included accessory renal veins
greater than one third the diameter of each renal vein
proper, IVC duplication, low right gonadal vein, and cava-
megaly. Procedure reports and venograms were reviewed
to determine whether abnormal and aberrant findings led
to a decision for a major change in VCF position. A major
change in VCF position was defined as placing the VCF in
the IVC above the renal veins or inability to place the VCF
just inferior (within 2 cm) to the lowest proper renal vein.
Deploying the VCF in the lower aspect of the IVC, just
above the iliac bifurcation, was considered a major change
Table I. Criteria for grading quality of nonselective
venograms
Venogram
quality Renal or common iliac veins visualized
Poor Neither renal vein or common iliac vein
Suboptimal One renal vein or one common iliac vein
Marginal One renal vein and one common iliac vein
One renal vein and both common iliac veins
Both renal veins and neither common iliac vein
Good Both renal veins and one common iliac vein
Excellent Both renal veins and both common iliac veins
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in position if the anatomy just below the renal veins was
compromised due to an aberrant anatomic or abnormal
finding.
A 2 test was used to compare abnormal and aberrant
venous findings between patients undergoing nonselective
and selective venography, and to determine whether these
findings led to a change in VCF position. An unpaired t test
was used to compare contrast volume between nonselective
and selective groups, and preprocedural and postproce-
dural creatinine concentrations. P  .05 was accepted as
statistically significant. Data are expressed as mean  SD.
RESULTS
Ninety-five VCFs were deployed in 94 patients (53%
male; mean age, 53 years [range, 15-90 years]). Risk factors
for venous thromboembolism are shown in Table II. Be-
fore VCF insertion, 57 patients (61%) underwent venous
duplex ultrasound scanning. Thirty-seven patients (39%)
had deep venous thrombosis, and 29 patients (31%) had
pulmonary embolism. Forty patients (44%) had an absolute
indication for VCF placement, and 54 (56%) had a relative
indication for VCF placement (Table III). The VCF was
deployed in the catheterization laboratory in 69 patients
(73.4%), the operating room in 20 patients (21.3%), and
the intensive care unit in 4 patients (4.3%). In one patient
(1.1%) a VCF was deployed in the left common iliac vein
with IVUS in the intensive care unit. The next day a second
VCF was correctly placed in the IVC before a major ortho-
pedic operation. Catheter access to the vena cava included
the right internal jugular vein in 44 patients (46.8%), right
common femoral vein in 41 patients (43.6%), right subcla-
vian vein in 6 patients (6.4%), and left common femoral
vein in 2 patients (2.1%). Access for the one patient (1.1%)
in whom two VCFs were required were the left common
femoral vein and right internal jugular vein.
VCFs were deployed empirically over the third lumbar
vertebrae in 2 patients (2.1%), and IVUS was used exclu-
sively before deployment in 10 patients (10.6%). Three
patients (3.2%) underwent both nonselective venography
and IVUS before VCF deployment. No aberrant or abnor-
mal findings were noted with either imaging method.
Venography was performed in 80 patients (85%), nonselec-
tive venography alone in 45 patients(56%) and additional
selective venography of major venous tributaries in 35
patients (44%). Frequency of selective venography used in
addition to nonselective venography by each vascular sur-
geon is shown in Table IV.
Selective catheterization was of both renal veins in 26
patients (32.5%), unilateral or accessory renal veins in 4
patients (5.0%), both common iliac veins in 7 patients
(8.8%), and unilateral common iliac vein in 10 patients
(12.5%). In 15 patients (18.8%) renal and iliac veins were
selectively catheterized. With the criteria defined in Table I,
16% of nonselective venograms were graded as excellent,
16% as good, 45.3% as marginal, 6.7% as suboptimal, and
16% as poor.
Six patients (7.5%) had abnormal findings at venogra-
phy. These included IVC or iliac vein thrombus in 2
patients (2.5%), significant IVC tortuosity in 1 patient
(1.3%), and IVC compression in 3 patients (3.8%). Four-
teen patients (17.5%) had aberrant anatomic findings.
These included accessory renal vein in 8 patients (10%),
left-sided vena cava or IVC duplication in 3 patients (3.8%),
large low-lying right gonadal vein in 2 patients (2.5%), and
cavamegaly in 2 patients (2.5.%). Three patients (3.8%) had
two aberrant or abnormal findings. These included cava-
megaly and accessory renal vein, IVC tortuosity and cava-
megaly, and IVC thrombus and low-lying right gonadal
vein in one patient each. Of the 80 patients undergoing
venography before VCF placement, 23% had abnormal or
aberrant anatomic findings. Abnormal or aberrant ana-
tomic findings were found significantly more often (P 
Table II. Risk factors for thromboembolic events in
patients with vena cava filter
Risk factor
No. of
patients %
Age 40 y 66 70.2
Male 50 53.2
Trauma 50 53.2
Prolonged surgery (3 h) 30 31.9
Malignancy 26 27.7
Previous thromboembolic event 18 19.1
Obesity 13 13.8
Spinal cord injury 11 11.7
Hypercoagulable state 5 5.3
Congestive heart failure 2 2.1
Oral contraception use 2 2.1
Nephrotic syndrome 2 2.1
Table III. Absolute and relative indications in patients
with vena cava filter
Indication
No. of
patients %
Absolute 40 44
Complications of anticoagulation
therapy
8 8.5
VTE with contraindication to
anticoagulation
23 25.5
PE with therapeutic
anticoagulation
5 5.3
Recurrent DVT with
anticoagulation therapy
3 3.2
Poor compliance with
anticoagulation therapy
1 1.1
Relative 54 57
Prophylaxis after trauma 43 45.7
Malignancy with VTE 4 4.3
DVT with prolonged bed rest 3 3.2
Malignancy with contraindication
to anticoagulation therapy
2 2.1
DVT with free-floating thrombus 1 1.1
Propagation of DVT with
anticoagulation therapy
1 1.1
VTE, Venous thromboembolism; PE, pulmonary embolism; DVT, deep
venous thrombosis.
JOURNAL OF VASCULAR SURGERY
November 2003930 Danetz et al
.001) at selective venography (17 of 35, 49%) compared
with nonselective venography (4 of 45, 9%).
Seven aberrant or abnormal findings required a change
in VCF position below the renal veins. These included five
accessory renal veins, one IVC compression, and one large
right gonadal vein. Six aberrant or abnormal findings re-
quired VCF placement above the renal veins. These in-
cluded two instances of cavamegaly, two IVC duplications,
one IVC compression, and one large right gonadal vein.
Eight aberrant or abnormal findings required no change in
VCF position. These included three accessory renal veins,
two IVC thrombi, one left-sided IVC, one IVC compres-
sion, and one tortuous IVC.
When examining the relationship of major venous trib-
utaries visualized on venograms to vertebral bony land-
marks, the lowest renal vein corresponded to the L1 verte-
bral body in 17.3%, L1-2 disk space in 36.5%, L2 vertebral
body in 34.6%, L2-3 disk space in 7.7%, and L3 vertebral
body in 3.8%. Similarly, the common iliac vein confluence
corresponded to the L5-S1 disk space in 3.8%, L5 vertebral
body in 80.8%, L4-5 disk space in 11.5%, and L4 vertebral
body in 3.8%. The relationship of venous tributaries to the
vertebral column is shown in Fig 1.
Of the entire cohort, the stainless steel Greenfield filter
(Meditech, Watertown, MA) was deployed in 21 patients
(22.3%), the titanium Greenfield filter (Meditech) in 37
patients (39.4%), and the TrapEase filter (Cordis) in 35
patients (37.2%). One patient (1.1%) received both a Trap
Ease filter and a titanium Greenfield filter. The TrapEase
filter was used more frequently toward the latter half of the
series, because of its smaller delivery profile (6F) and bidi-
rectional deployment capability. The decision to deploy a
VCF in a position other than just inferior to the lowest
proper renal vein was made significantly more often (P 
.003) in patients undergoing selective venography (11 of
35, 31.4%) compared with those undergoing nonselective
venography (2 of 45, 4.4%).
A mean of 79.9  62.5 mL (range, 30-380 mL) of
intravenous contrast medium was used during venography.
Patients undergoing additional selective venography re-
ceived significantly more intravenous contrast medium (P
 .001) than those undergoing only nonselective venogra-
phy (111.7 73.9 mL vs 51.1 28.9 mL, respectively). In
56 of 80 patients (70%) undergoing venography serum
creatinine concentration was measured before VCF and at
4 to 7 days of follow-up. Two patients undergoing hemo-
dialysis because of chronic renal failure were excluded from
the analysis. Follow-up serum creatinine concentration in
patients undergoing only nonselective venography (0.78
0.26 mg/dL) was significantly lower (P  .02) compared
with serum creatinine concentration before VCF (0.92 
0.35 mg/dL). For patients undergoing additional selective
venography (n  21), serum creatinine concentration be-
fore and after VCF placement (0.84 0.20 mg/dL vs 0.77
 0.17 mg/dL, respectively) did not significantly change
(P  .22). As a whole, serum creatinine concentration did
not increase by more than 1 mg/dL in any patients, nor did
any patient require hemodialysis as a result of contrast
agent–induced nephropathy.
Seven patients (8.8%) had complications due to VCF
deployment. Three patients had small hematomas at the
access site, none of which required surgery or transfusion.
One patient had a pneumothorax, which did not require
tube thorocostomy, and subsequently resolved. In one
patient who underwent concomitant aortography, a com-
mon femoral artery pseudoaneurysm developed, which was
successfully managed with duplex ultrasound compression.
In one patient, initial placement of the access sheath was in
the common femoral artery, without untoward effect. In
one patient, a VCF was wrongly placed in the left common
iliac vein with IVUS.
Five patients (5.3%) died within 30 days of VCF place-
ment. Although no autopsies were performed, none of the
deaths was attributed to complications or failure of VCF.
Causes of death included brain death, multiple system
organ failure, and advanced malignancy. At mean follow-up
after VCF placement of 19 months (range, 3-56 months),
recurrent venous thromboembolism occurred in four pa-
tients (4.3%). Three patients had deep venous thrombosis,
and one patient had a pulmonary embolism. This patient
had extensive upper extremity and tricuspid valve throm-
bus, and subsequently required pulmonary embolectomy.
DISCUSSION
The use of VCFs has dramatically reduced the occur-
rence of pulmonary embolism in patients at high risk.17
Nevertheless, recurrent pulmonary embolism after VCF
placement is as high as 4.4%.18-20 Considering the variation
Table IV. Analysis by vascular surgeon of number of vena cava filter deployments with selective venography and where
the procedure was performed
Vascular
surgeon
VCFs
deployed
Nonselective
venography
Selective
venography*
Catheterization
laboratory
Operating
room Bedside
R.B.M. 17 16 4 13 3 1
L.A.G. 24 24 4 19 3 2
M.M.S. 16 6 2 9 5 2
M.A.M. 7 7 4 6 1 0
D.E.R. 8 4 0 0 8 0
K.J.H. 23 23 21 22 1 0
Total 95 80 35 69 21 5
*All selective venography was performed in the catheterization laboratory.
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of venous anatomy and the potential for vena cava disease,
proper position of a VCF is paramount in prevention of
pulmonary embolism. Obtaining correct VCF position is,
in this modern era, far more dependent on adequate vena
cava visualization than on device design or physician train-
ing. Our results demonstrate two important and related
findings. In using additional selective catheterization to
obtain venograms of major venous tributaries to the IVC,
significantly more aberrant anatomic and abnormal venous
findings were discovered. More important, most of these
discoveries led to a decision to place the VCF in an alternate
position. Twenty-three percent of our patients undergoing
venography had aberrant anatomy or abnormal venous
findings. Anomalies were discovered in 49% of patients
undergoing selective venography, compared with 9% of
patients undergoing only nonselective venography. More-
over, 31.4% of patients with selective venography had a
change in VCF position, compared with 4.4% of patients
with only nonselective venography.
These findings may have important implications when
considering the use of other methods of vena cava localiza-
tion or visualization for proper positioning of a VCF. Not
uncommonly, empiric placement of a VCF in the IVC at
the approximate level of the L3 vertebral body with fluo-
roscopy is standard practice. Given the results of this study,
in which the lowest renal vein visualized at venography was
aligned with precise vertebral levels, caution should be used
in continuing this method of VCF deployment. More than
1 in 10 patients undergoing venography in our study had a
renal vein between the top of the L2-3 disk space and the
bottom of the L3 vertebral body. These findings lead us to
recommend abandoning the technique of empiric place-
ment with bony landmarks, despite safe placement of a
small number of VCFs (n  2) in our patients with this
method.
More recently, transabdominal duplex ultrasound7,8 or
IVUS9-11 is being used to visualize the vena cava for VCF
placement. The advantages of these methods include ability
to perform the procedure at the bedside, and cost-reduc-
tion.7-11 From a practical standpoint, the preciseness of
vena cava visualization is highly dependent on the technol-
ogist’s skill and the interpreter’s abilities. Thus the learning
curve is steep with these methods, as exemplified by a recent
study that reported VCF maldeployment in 6 patients.8 In
contrast, no VCFs were maldeployed with venography in
our patient cohort, while we experienced the steep learning
curve of using ultrasound as exemplified by one VCF
incorrectly placed in the common iliac vein. The discovery
from this report that 23% of patients had either aberrant
venous anatomy or an abnormal finding provides useful
information for those centers that use ultrasound as the
primary method of vena cava visualization. Although we
agree that use of ultrasound at the bedside may be necessary
in a small number of clinically unstable patients in the
intensive care unit, most patients can be safely transported
to the catheterization laboratory, as demonstrated with our
patient cohort.
Relying completely on nonselective venography for
optimal VCF position may also have limitations when de-
siring optimal VCF position. Even with the use of a power
injector, optimal contrast load, and a 15-inch image inten-
sifier, we observed 68% of nonselective venography to be
marginal, suboptimal, or poor (Table I). It is interesting
that of the 24 nonselective venograms graded of excellent
or good quality, only 1 showed a large accessory renal vein
that led to placing the VCF in a much lower position.
Others have had similar findings. Hicks et al12 discovered
that an additional 18% of patients had significant venous
anomalies at subsequent selective renal venography. Similar
to our findings, they noted that findings at venography led
to change in VCF position in 30% of patients. Mejia et al14
Fig 1. Diagram illustrates relationship of lowest renal veins and
common iliac vein confluences to lumbar vertebral bodies and disk
spaces.
JOURNAL OF VASCULAR SURGERY
November 2003932 Danetz et al
and Martin et al,13 using only nonselective venography,
found change in VCF position necessary in 11% and 15% of
patients, respectively. Of patients undergoing only nonse-
lective venography in our study (n  45), 4 had aberrant
anatomic or abnormal venous findings. Two of these pa-
tients required a change in VCF position. Of interest, it
could be postulated that in the 41 patients in whom aber-
rant anatomic or abnormal venous findings were not de-
tected, anomalies were missed in an additional 15 patients
because selective catheterization was not used. Fig 2 shows
how a major aberrant anatomic finding can be missed when
only nonselective venography is used.
The retrospective nature of patient follow-up did not
provide reliable information as to whether the additional
use of selective venography for VCF placement made a
difference in prevention of pulmonary embolism during
long-term follow-up. It should be emphasized that the
hypothesis of this study was not to address this important
issue, but to determine whether selective catheterization
led to a change in deployment of the VCF away from the
usual position just below the renal veins. From a monetary
perspective, the relatively small difference in hospital
charges to patients did not provide a compelling argument
for not using selective venography. Sample data from four
patients showed an approximate charge of $6500 for VCF
placement in the operating room (empiric placement with-
out venography), $7300 with IVUS at the bedside, $5900
with nonselective venography, and $7700 with selective
venography.
Selective catheterization in our patient cohort was per-
formed at the discretion of the attending vascular surgeon.
Lack of a strict protocol as to when selective venography
was to be used and the retrospective nature of the study
represent significant bias. Whereas one attending vascular
surgeon used selective venography almost routinely to fur-
ther delineate the major venous tributaries, others used it
based on the initial findings of nonselective venography
(Table IV). Nevertheless, a significantly higher proportion
of patients were discovered to have aberrant anatomic or
abnormal venous findings when selective venography was
used. This provides more evidence for physicians, who
routinely use venography to place VCFs, to have a low
threshold to selectively catheterize the renal, iliac, and
other large veins draining into the vena cava. Alternatively
stated, if nonselective venography does not enable easy
identification of both renal veins and most of the left iliac
Fig 2. Digital subtraction angiograms show nonselective venogram of inferior vena cava (A) and subsequent selective
venogram of left common iliac vein (B). Duplicated inferior vena cava (arrow) leading to left renal vein is shown only
with selective venography. Vena cava filter was deployed in inferior vena cava above renal veins.
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vein (primarily for accessory vena cava identification), selec-
tive venography should be used to define these and any
other abnormality to optimize VCF position.
We acknowledge the contributions of two previous
faculty members of Southern Illinois University. Those
cited in Methods and Table IV, not previous listed as
authors, include Mark A. Mattos, MD (M.A.M.) and Mau-
rice S. Solis, MD (M.S.S.).
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